Navigacijska pot

Pošlji prijatelju
RSS
google +
Različica za tiskanje

Novica (Na delu)

Izbor in objava novic in informacij o dogodkih na portalu Zdravje-EU sta samodejna postopka (na podlagi kriterijev Evropske komisije), zato se lahko zgodijo napake pri razvrščanju.

New publication: Scientific Committees - 2012 Opinions CD now available»  europa.eu

European Commission - When preparing its policy and proposals relating to consumer safety, public health and the environment, the Commission relies on independent Scientific Committees to provide it [...]

Health and safety at the crossroads: EU-OSHA’s annual report 2012 »  europa.eu

Against a background of continuing economic uncertainty, in its 2012 annual report the European Agency for Safety and Health at Work (EU-OSHA) shows how it has continued to work hard to promote the i[...]

ECDC report: Public health benefits of partner notification for sexually transmitted infections and HIV»  europa.eu

The legal context for partner notification varies within Europe due to diverse legal and policy frameworks, cultural influences and social factors. The report presents key findings and recommendation[...]

OiRA—the Online interactive Risk Assessment project—risk assessment made easy»

Intended for use by micro and small organisations, the tools enable a quick and efficient risk assessment process, reducing the costs that result from accidents and illness at work and improving overall business performance.

EU employment and social situation - Just Published - EU Bookshop»  europa.eu

Quarterly review March 2013 Special supplement on demographic trends[...]

EU employment and social situation - Just Published - EU Bookshop»  europa.eu

Quarterly review March 2013[...]

Health and safety at work: Commission opens public consultation on future EU policy framework»  europa.eu

Public consultations[...]

Health and safety at work: Commission opens public consultation on future EU policy framework »

The European Commission has launched a public consultation to gather insights and contributions from the public further to results of the evaluation of the European Strategy on Safety and Health at Work 2007-2012.

Scientific guideline: Draft guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues, draft: consultation open»  europa.eu

This guideline lays down the non-clinical and clinical requirements for a biological medicinal product claiming to be similar to another one already marketed ([...]

Scientific guideline: Guideline on good pharmacovigilance practices (GVP): Module VI – Management and reporting of adverse reactions to medicinal products, draft: consultation open»  europa.eu

This Module addresses the legal requirements detailed in Title IX of Directive 2001/83/EC [DIR] and Chapter 3 of Regulation (EC) No 726/2004 [REG], which are applicable to competent authorities in Me[...]

Regulatory and procedural guideline: Draft guideline on the acceptability of names for human medicinal products processed through the centralised procedure, draft: consultation open»  europa.eu

The current update of this guideline provides further recommendations on the requirements for acceptability and submission of proposed (invented) names of medicinal products processed through the cen[...]

Youth employment: EU support for apprenticeship and traineeship schemes»  europa.eu

European Commission MEMO Brussels, 7 June 2013 The importance of good quality apprenticeships and traineeships in the transition from education to work and for implementing the Youth Guarantee was th[...]

Scientific guideline: Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of venous thromboembolic disease, draft: consultation open»  europa.eu

Since the publication of the EMA Guidance on clinical investigation of medicinal products for the treatment of venous thromboembolic disease (CPMP/EWP/563/98) in 2000, there has been an intense resea[...]

eNews: Tobacco products proposal: Setting the record straight on 10 common myths»  europa.eu

Directorate General for Health & Consumers[...]

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 May 2013»  europa.eu

This page provides an overview of the opinions adopted at the May 2013 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes.[...]

Tobacco products proposal: Setting the record straight on 10 common myths»  europa.eu

European Commission MEMO Brussels, 30 May 2013 Every year, smoking kills almost 700,000 people in Europe and causes millions more to suffer from diseases associated with smoking, including cancers, c[...]

Scientific guideline: Draft guideline on the clinical development of medicinal products intended for the treatment of pain, draft: consultation open»  europa.eu

This document is intended to give guidance on the investigation of medicinal products to be used in the treatment of nociceptive pain and / or of central and peripheral neuropathic pain.[...]

Green jobs and occupational safety and health - Just Published - EU Bookshop»  europa.eu

Foresight on new and emerging risks associated with new technologies by 2020 : report[...]

Public consultation on advanced therapy medicinal products»  europa.eu

European Commission -  A summary of the responses is here. Academic GMP Research Consortium[...]

Minimum pricing will bring “substantial health and social benefits” says new IAS report»  eurocare.org

A new report published today by IAS summarises the latest evidence on minimum pricing and rebuts some common criticisms (often from vested interest groups) of the policy.[...]

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2013 (europa.eu, ) »

This page provides an overview of the opinions adopted at the April 2013 meeting of the CHMP and other important outcomes.[...]

European Medicines Agency recommends approval of combined advanced-therapy product (europa.eu, ) »

The European Medicines Agency?s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for MACI (matrix-induced autologous chondrocyte implantation), an advance[...]

Review of the CAP schemes providing agricultural products to school children»  epha.org

This article is a contribution to DG Agriculture public consultation on the Review of the CAP Schemes Providing Agricultural Products to School Children EPHAC response to CONSULTATION ON THE REVIEW O[...]

[European Network for Workplace Health Promotion] Guide to good practices on chronically ill employees»  epha.org

The European Network for Workplace Health Promotion (ENWHP) has released its European Guide to Good Practice on chronically ill employees. Chronic illness poses a major challenge for public health - [...]

European statistics on accidents at work (ESAW) - Just Published - EU Bookshop»  europa.eu

Summary methodology[...]

Green jobs and occupational safety and health - Just Published - EU Bookshop»  europa.eu

Foresight on new and emerging risks associated with new technologies by 2020 : summary[...]

Demanding physical work associated with an increased risk of cardiovascular disease »  escardio.org

Additional physical activity during leisure time in those who are already physically exhausted from their daily occupation does not induce a 'training' effect but rather an overloading effect on the [...]

Working Group on the European Workforce for Health, Brussels, 12 Arpil 2013 - Presentations now available»  europa.eu

European Commission - Brussels, 12 April 2013  [...]

Periodic Report Summary - CHANCE (Low-cost technologies and traditional ingredients for the production of affordable, nutritionally correct foods improving health in population groups at risk of pover»  europa.eumsw8

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA Project context and objectives: Although consciousness of the relationship between diet and health is increasing among the general population, currently t[...]

Guideline on good pharmacovigilance practices: Product-or population-specific considerations I: Vaccines for prophylaxis against infectious diseases: consultation open»  europa.eu

The objective of this module is to strengthen the conduct of pharmacovigilance for vaccines. It should be noted that the overall objectives and processes of pharmacovigilance are no different for vac[...]

Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 9-11 April 2013»  europa.eu

The Committee adopted by consensus a positive opinion for an initial marketing authorisation application for Equilis West Nile from Intervet International B.V. a vaccine for the active immunisation o[...]

Making safer composite materials for ship building»  europa.eu

Just like any mode of transport that carries members of the public, ships are subject to strict safety regulations. These not only cover the use and maintenance of the vessel but also its constructio[...]

Are ‘green jobs’ safe? »  europa.eu

With pressure to reduce carbon emissions, reduce waste, increase energy efficiency and the proportion of renewable energy, the EU is set for a rapid growth in the number of `green jobs' - jobs which [...]

Concept paper on the development of medicinal products for the treatment of autism spectrum disorder: consultation open»  europa.eu

Autism spectrum disorders (ASDs) are a group of neurodevelopmental disabilities with symptoms typically presenting before the age of 3 years and persisting into adulthood. They are described as[...]

Speech: European strategies for health and safety at work: the role of social partners»  europa.eu

European Commission László ANDOR European Commissioner responsible for Employment, Social Affairs and Inclusion European strategies for health and safety at work: the role of social partners European[...]

Draft guideline on the declaration of the quantitative composition / labelling of biological medicinal products that contain modified proteins as active substance: consultation open»  europa.eu

Draft guideline on the declaration of the quantitative composition / labelling of biological medicinal products that contain modified proteins as active substance Draft guideline on the declaration o[...]

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 March 2013»  europa.eu

This page provides an overview of the opinions adopted at the March 2013 meeting of the CHMP and other important outcomes.[...]

Working conditions: Commission urges Member States to implement ILO domestic workers convention»  europa.eu

European Commission Press release Brussels, 21 March 2013 The European Commission has presented a proposal for a Council Decision authorising Member States to ratify the International Labour Organisa[...]

European Medicines Agency reminds companies of timeframe to submit product-information translations in Croatian»  europa.eu

The European Medicines Agency reminds applicants and marketing-authorisation holders that they need to submit of translations of product information in Croatian for opinions as of April 2013.[...]

Scientific guideline: guideline on the clinical development of medicinal products intended for the treatment of chronic primary immune thrombocytopenia, consultation open»  europa.eu

This guideline describes the information on the clinical development to be documented when an application for a marketing authorisation for a medicinal product is made for the treatment of chronic pr[...]

European Medicines Agency updates product information template to label medicines subject to additional monitoring and encourage adverse-reaction reporting»  europa.eu

As part of the implementation of the European Union (EU) pharmacovigilance legislation, the European Medicines Agency has updated the product information template to allow easy identification of huma[...]

Zdravstvene teme: Od A do Ž

Izbor in objava novic in informacij o dogodkih na portalu Zdravje-EU sta samodejna postopka (na podlagi kriterijev Evropske komisije), zato se lahko zgodijo napake pri razvrščanju.